Healio (3/23, Weller) reports, “Patients self-reported varying opinions on cannabis use and its efficacy in alleviating the symptoms of Parkinson’s disease [PD],” investigators concluded after distributing “an anonymous survey to ‘constituents’ of the Parkinson’s Foundation with PD; they reported a 17.6% response rate.” Researchers then included “1,064 patients (mean age, 71.2 years; mean disease duration, 7.4 years) who provided complete responses…in the final analysis.” The study revealed that “most patients ‘recognize that cannabis is no substitute for PD medications,’” the study’s lead author said. The findings were published online in NPJ Parkinson’s Disease. (SOURCE: APA Headlines)